BIORA THERAPEUTICS INC Stock (BIORQ.US) Real-time Quotes - Financial Data - Analyst Ratings

Company Encyclopedia

BIORA THERAPEUTICS INC

BIORQ.US

1.935 T

BIORQ.USMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update

BiotechnologyIndustry

Industry Ranking181/401

Industry medianC

Industry averageD

Score Analysis

Peer Comparison

Criteria
Rating
Profit ScoreB
- ROE31.56%A
- Profit Margin-3535.76%E
- Gross Margin100.00%A
Growth ScoreA
- Revenue YoY4855.56%A
- Net Profit YoY74.24%A
- Total Assets YoY-58.20%E
- Net Assets YoY10.23%B
Cash ScoreB
- Cash Flow Margin-2.83%D
- OCF YoY4855.56%A
Operating ScoreE
- Turnover0.04E
Debt ScoreE
- Gearing Ratio835.12%E

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Athyrium Capital Management, LP	24.71%	No Change	24/03/2025
Margaret Ellen Taggett	6.71%	No Change	07/04/2025
Davidson Kempner Capital Management LP	1.24%	No Change	30/06/2025
Aditya P. Mohanty	0.52%	No Change	18/10/2024
Context Capital Management LLC	0.5%	No Change	30/06/2025
Eric d'Esparbes	0.19%	No Change	18/10/2024
Clarke Neumann	0.18%	No Change	18/10/2024
Jeffrey Donald Alter	0.04%	No Change	18/10/2024
Brian L. Kotzin	0.04%	No Change	18/10/2024
Lynne M. Powell	0.04%	No Change	18/10/2024

News

Biora Therapeutics completes restructuring process, now privately held; aims to speed up BioJet™ platform development.

After completing restructuring, Biora has transitioned into a privately held firm, equipped with long-term funding aimed at expediting the advancement of the BioJet™ platform.

Unusual Whales·05/09/2025 05:52

Unusual Whales·05/09/2025 05:52

Biora Therapeutics finishes restructuring, now privately held with funds to boost BioJet™ platform development.

After completing a restructuring process, Biora has transitioned into a privately owned company. The company has secured long-term funding that will be utilized to expedite the advancement of the BioJet™ platform. This move signals a significant milestone for Biora as they focus on enhancing their technology. The specific amount of financing and other details surrounding the transition were not disclosed publicly.

Unusual Whales·05/05/2025 03:33

Unusual Whales·05/05/2025 03:33

Biora Therapeutics exits restructuring as a private company, securing funding to advance BioJet™ platform.

Following a restructuring process, Biora has transitioned into a privately owned company, securing long-term financing to expedite the advancement of the BioJet™ platform. This move positions the company to drive growth and innovation while operating as a private entity. Through this development, Biora aims to enhance its efforts in further developing the BioJet™ platform.

Unusual Whales·04/20/2025 07:07

Unusual Whales·04/20/2025 07:07

Biora Therapeutics, a privately held company, completes restructuring process for development of BioJet™ platform.

After undergoing restructuring, Biora has transitioned into a privately owned company. The firm has secured long-term funding to expedite the advancement of its BioJet™ platform.

Unusual Whales·04/18/2025 06:32

Unusual Whales·04/18/2025 06:32

Biora Therapeutics completes restructuring, now private with funding for BioJet™ platform development.

After completing a reorganization process, Biora has transitioned into a privately owned entity. The company has secured significant long-term funding to expedite the advancement of its BioJet™ platform. This move is aimed at boosting innovation and growth within the company.

Unusual Whales·04/11/2025 08:17

Unusual Whales·04/11/2025 08:17